Biotech · Private company · Newton, MA, US
Lumicell, Inc.
Track this companyFree. Adds Lumicell, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials113 recruiting or active
Pipeline programs10From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline10
- Study Device ArmPhase 3 · Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- LUM 2.6 Imaging DevicePhase 2 · Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
- LUM 2.6 Imaging DevicePhase 2 · Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- Lum Imaging SystemPhase 2 · Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- LUM Imaging SystemPhase 2 · Peritoneal MetastasesClinicalTrials.gov · fetched Nov 12, 2026
- LUM Imaging SystemPhase 2 · Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- LUM015Phase 2 · Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- LUM015Phase 2 · Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
- LUM Imaging SystemLow Grade Glioma of BrainClinicalTrials.gov · fetched Nov 12, 2026
- LUM Imaging SystemPancreatic CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials11
- Post-market Safety Study of LUMISIGHTRECRUITING · started Sep 30, 2026ClinicalTrials.gov NCT07572162 · fetched Nov 12, 2026
- Post-market Evaluation of LumiSystem: Intraoperative Margin Performance and Clinical Utility (IMPACT) RegistryRECRUITING · started Sep 30, 2026ClinicalTrials.gov NCT07616856 · fetched Nov 12, 2026
- Feasibility Study of LUM Imaging System for Pancreatic CancerNA · WITHDRAWN · started Jan 1, 2026ClinicalTrials.gov NCT04276909 · fetched Nov 12, 2026
- Feasibility Study of Intraoperative Detection of Residual Cancer in Breast Cancer PatientsPHASE2 · TERMINATED · started Sep 1, 2020ClinicalTrials.gov NCT04440982 · fetched Nov 12, 2026
- Investigation of Novel Surgical Imaging for Tumor ExcisionPHASE3 · COMPLETED · started Nov 4, 2019ClinicalTrials.gov NCT03686215 · fetched Nov 12, 2026
- Feasibility of the LUM Imaging System for Detection of Cancer to the BrainNA · TERMINATED · started May 3, 2019ClinicalTrials.gov NCT03717142 · fetched Nov 12, 2026
- Feasibility of the LUM Imaging System for Detection of Prostate CancerPHASE1_PHASE2 · TERMINATED · started Mar 20, 2019ClinicalTrials.gov NCT03441464 · fetched Nov 12, 2026
- Feasibility of the LUM Imaging System for Peritoneal Surface MalignanciesPHASE1_PHASE2 · COMPLETED · started Mar 18, 2019ClinicalTrials.gov NCT03834272 · fetched Nov 12, 2026
- Intraoperative Detection of Residual Cancer in Breast CancerPHASE2 · COMPLETED · started Feb 6, 2018ClinicalTrials.gov NCT03321929 · fetched Nov 12, 2026
- Feasibility of the LUM Imaging System for Detection of Gastrointestinal CancersPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Aug 4, 2016ClinicalTrials.gov NCT02584244 · fetched Nov 12, 2026
- Feasibility Study of Intraoperative Imaging in Breast CancerPHASE1_PHASE2 · COMPLETED · started Jun 1, 2015ClinicalTrials.gov NCT02438358 · fetched Nov 12, 2026
NIH awards1
- SBIR Topic 463: Clinical evaluation for early detection of esophageal cancer with a novel fluorescence endoscope and pegulicianine, a novel fluorescent probeFiscal year 2024 · $399KNIH RePORTER 75N91024C00081-0-9999-1 · fetched Nov 12, 2026